Published in Blood on August 01, 1977
Cerebral venous thrombosis in paroxysmal nocturnal hemoglobinuria: a series of 15 cases and review of the literature. Medicine (Baltimore) (2015) 0.88
New insight into the effects of heparinoids on complement inhibition by C1-inhibitor. Clin Exp Immunol (2016) 0.76
Identification of cell-penetrating peptides that are bactericidal to Neisseria meningitidis and prevent inflammatory responses upon infection. Antimicrob Agents Chemother (2013) 0.75
Autoimmune neutropenia. Blood (1993) 1.52
Mechanisms of immune lysis of red blood cells in vitro. I. Paroxysmal nocturnal hemoglobinuria cells. J Clin Invest (1973) 1.29
Mechanisms of immune lysis of the red cells in hereditary erythroblastic multinuclearity with a positive acidified serum test and paroxysmal nocturnal hemoglobinuria. J Clin Invest (1974) 1.24
Chlorpropamide-induced immune hemolytic anemia. N Engl J Med (1970) 1.20
Quantitative influence of antibody and complement coating of red cells on monocyte-mediated cell lysis. J Clin Invest (1978) 1.18
Pulmonary and hepatic complications of methotrexate therapy of psoriasis. JAMA (1971) 1.14
Measurement of the third component of complement bound to red blood cells in patients with the cold agglutinin syndrome. J Clin Invest (1973) 1.10
The lysis of paroxysmal nocturnal haemoglobinuria red cells by serum and cobra factor. Br J Haematol (1972) 1.10
Hemorrhagic thrombocythemia; control of postsplenectomy thrombocytosis with melphalan. Blood (1970) 1.03
Felty's syndrome without splenomegaly. Am J Med (1979) 0.94
Home as a place to die. Am J Nurs (1980) 0.93
Sudden death during doxorubicin administration. Cancer (1979) 0.92
Complement-dependent immune adherence measured with human granulocytes: changes in the antigenic nature of red cell-bound C3 produced by incubation in human serum. Clin Immunol Immunopathol (1973) 0.91
Complement-mediated autoimmune thrombocytopenia. Monoclonal IgM antiplatelet antibody associated with lymphoreticular malignant disease. N Engl J Med (1987) 0.88
Transient acquired factor X deficiency associated with pneumonia. N Y State J Med (1984) 0.86
Recurrent thrombocytopenia following idiopathic thrombocytopenic purpura. The importance of platelet-bound IgG in establishing cause. Arch Intern Med (1980) 0.86
Immunologic mechanisms of hemolysis in autoimmune hemolytic anemia. Pathobiol Annu (1978) 0.86
Complement activation by heparin-protamine complexes during cardiopulmonary bypass: effect of C4A null allele. J Thorac Cardiovasc Surg (1997) 0.84
Autoimmune granulocytopenia. Annu Rev Med (1980) 0.82
I and i antigens on normal and leukemic leukocytes. Cancer (1978) 0.82
Felty's syndrome: effects of splenectomy upon granulocyte count and granulocyte-associated IgG. Ann Intern Med (1981) 0.81
Replication of type I herpes simplex virus in primary cultures of hairy cell leukemic leukocytes. Am J Pathol (1978) 0.80
Endogenous carbon monoxide production measured by gas-phase analysis: an estimation of heme catabolic rate. J Lab Clin Med (1971) 0.80
Antibodies to granulocyte precursors in selective myeloid hypoplasia and other suspected autoimmune neutropenias: use of HL-60 cells as targets. Blood (1987) 0.80
Activation of human complement by immunoglobulin G antigranulocyte antibody. J Clin Invest (1982) 0.79
Complement activation by artificial blood substitute Fluosol: in vitro and in vivo studies. Transfusion (1991) 0.79
Alpha-interferon for severe cold agglutinin disease. Ann Intern Med (1989) 0.79
Evaluating the superior vena cava syndrome. JAMA (1981) 0.79
Medical management of chronic cancer pain. JAMA (1979) 0.78
Complement-activating antineutrophil antibody in systemic lupus erythematosus. Am J Med (1985) 0.78
Use of total lymphoid irradiation (TLI) in studies of the T cell-dependence of autoantibody production in rheumatoid arthritis. J Immunol (1984) 0.78
Granulocyte antibodies in leukaemic chronic lymphoproliferative disorders. Br J Haematol (1987) 0.78
Two biochemical markers in lymphocyte subpopulations. Br J Haematol (1976) 0.77
Human lymphocyte complement receptors. Stimulation of lymphocyte RNA synthesis by complement-coated human red cells. Clin Immunol Immunopathol (1977) 0.77
Neutrophil lactoferrin release during open heart surgery is unrelated to complement activation. ASAIO J (1994) 0.77
Autoimmune neutropenia in Hodgkin's disease. Arch Intern Med (1982) 0.77
Failure of splenectomy in Felty's syndrome. The role of antibodies supporting granulocyte lysis by lymphocytes. N Engl J Med (1981) 0.77
The effect of synthetic androgens in hereditary angioneurotic edema: alteration of C1 inhibitor and C4 levels. Trans Assoc Am Physicians (1976) 0.77
Light chain composition of serum granulocyte binding immunoglobulins. Am J Hematol (1991) 0.76
Human lymphocyte complement receptors. Quantitative requirements for C3 of normal and chronic lymphocyte leukemia lymphocytes. J Clin Invest (1977) 0.76
Melphalan therapy of polycythemia vera. Blood (1970) 0.76
Diving decompression fails to activate complement. Undersea Hyperb Med (1997) 0.76
Effect of antigen site and complement receptor status on the rate of cleavage of C3c antigen from red cell bound C3b. Blood (1988) 0.76
Granulocytes in Felty's syndrome. Ann Intern Med (1977) 0.75
Immune hemolytic anemias. Mod Treat (1971) 0.75
Leukopheresis therapy of leukemic reticuloendotheliosis (hairy cell leukemia). Blood (1979) 0.75
Primary amyloidosis, pure red cell aplasia, and Kaposi's sarcoma in a single patient. Cancer (1979) 0.75
Teardrop-shaped red cells in autoimmune hemolytic anemia. Am J Hematol (1986) 0.75
Effect of RBCs on the activation of human complement by heparin-protamine complexes. Blood (1988) 0.75
Antidepressant therapies and the cardiac patient: a review. Mil Med (1982) 0.75
In vitro activation of human complement by nitrogen bubbles. Undersea Biomed Res (1991) 0.75
T-lymphocytes escape membrane defect in paroxysmal nocturnal haemoglobinuria. Br J Haematol (1983) 0.75
Acquired factor VIII inhibitor with squamous cell cancer of the epiglottis. Arch Otolaryngol Head Neck Surg (1990) 0.75
In vitro activation of human complement by polyacrilonitrile dialyzer membrane assayed by complement binding to bystander red cells. ASAIO J (1992) 0.75
Splenectomy in Felty's syndrome. Ann Intern Med (1982) 0.75
Quantitation of warm reactive IgG antilymphocyte autoantibodies in systemic lupus erythematosus. Clin Immunol Immunopathol (1980) 0.75
Spurious neutropenia: ethylenediaminetetraacetate-dependent in vitro neutrophil agglutination. N Y State J Med (1991) 0.75
[Hospice: part II]. Kango (1982) 0.75
Antibody-dependent lymphocyte-mediated granulocyte cytotoxicity in man. Blood (1978) 0.75
Immune neutropenia. Prog Clin Biol Res (1984) 0.75
Flecanide-induced immune neutropenia. Documentation of a hapten-mediated mechanism of cell destruction. Arch Intern Med (1987) 0.75